March 31, 2021 at 11:28PM TRG Rapid Inquiry Program (TRIP)

As a result of the July 2020 update the FDA's guidance document, "Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use", FDA extended the TRIP program. It ended on March 31, 2021.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/35fzlpz